new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)





Similar
Filing Names

Incyte Corporation
Incyte Corporation A Delaware Corporation
Incyte Corporationn A Delaware Corporation
  

Incyte Corporation patents

Bulk PDF Downloads
Recent patent applications related to Incyte Corporation. Incyte Corporation is listed as an Agent/Assignee. Note: Incyte Corporation may have other listings under different names/spellings. We're not affiliated with Incyte Corporation, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "I" | Incyte Corporation-related inventors




Date Incyte Corporation patents (updated weekly) - BOOKMARK this page
01/28/10Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
12/01/16Heteroaryl substituted pyrrolo[2,3-b] pyridines and pyrrolo[2,3-b] pyrimidines as janus kinase inhibitors
12/01/16Processes and intermediates for making a jak inhibitor
12/01/16Pyridineamine compounds useful as pim kinase inhibitors
12/01/16Methods for diagnosing diseases associated with human signal peptide-containing molecules
11/24/16Salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
11/17/16Heterocyclic compounds and uses thereof
11/10/16Imidazotriazines and imidazopyrimidines as kinase inhibitors
10/06/16Bipyrazole derivatives as jak inhibitors
10/06/16Heterocyclic compounds as lsd1 inhibitors
09/29/16Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1
09/29/16Pyrazine derivatives as fgfr inhibitors
09/29/16Methods of diagnosing cancer
09/22/16Heteroaryl substituted pyrrolo[2,3-b] pyridines and pyrrolo[2,3-b] pyrimidines as janus kinase inhibitors
09/15/16Bicyclic azaheterocyclobenzylamines as pi3k inhibitors
09/08/16Processes for preparing jak inhibitors and related intermediate compounds
09/08/16Salts and processes of preparing a pi3k inhibitor
08/25/16Bicyclic heterocycles as fgfr4 inhibitors
08/25/16Bicyclic heterocycles as fgfr4 inhibitors
08/25/16Bicyclic heterocycles as fgfr4 inhibitors
08/11/16Aza-heteroaryl compounds as pi3k-gamma inhibitors
08/04/161,2,5-oxadiazoles as inhibitors of indoleamine 2,3- dioxygenase
08/04/16Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor
07/28/16Bicyclic heterocycles as bet protein inhibitors
06/16/16Tricyclic heterocycles as bet protein inhibitors
06/09/16Tricyclic heterocycles as bet protein inhibitors
05/19/16Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitors
05/19/16Imidazo[1,2-b][1,2,4]triazines as c-met inhibitors
05/12/16Antibodies to human signal peptide-containing proteins
04/28/16Bicyclic heterocycles as fgfr4 inhibitors
03/17/16Tricyclic heterocycles as bet protein inhibitors
03/10/163-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitors
02/18/16Tricyclic heterocycles as bet protein inhibitors
01/28/16Heterocyclylamines as pi3k inhibitors
01/28/16Tricyclic fused thiophene derivatives as jak inhibitors
01/28/16Heterocyclylamines as pi3k inhibitors
01/21/16Tricyclic fused thiophene derivatives as jak inhibitors
01/14/16Triazolopyridines and triazolopyrazines as lsd1 inhibitors
01/14/16Imidazopyridines and imidazopyrazines as lsd1 inhibitors
01/14/16Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitors
01/14/16Imidazopyrazines as lsd1 inhibitors
01/14/16Triazolopyridines and triazolopyrazines as lsd1 inhibitors
01/14/16Bicyclic heteroaromatic carboxamide compounds useful as pim kinase inhibitors
01/07/16Treatment of b-cell malignancies by a combination jak and pi3k inhibitors
12/17/15Bicyclic heteroarylaminoalkyl phenyl derivatives as pi3k inhibitors
12/03/15Treatment of chronic neutrophilic leukemia (cnl) and atypical chronic myeloid leukemia (acml) by inhibitors of jak1
12/03/15Processes of preparing a jak1 inhibitor and new forms thereto
11/19/15Thiazolecarboxamides and pyridinecarboxamide compounds useful as pim kinase inhibitors
11/19/15Amido compounds and their use as pharmaceuticals
11/05/15Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitors
10/29/151h-pyrrolo[2,3-c]pyridin-7(6h)-ones and pyrazolo[3,4-c]pyridin-7(6h)-ones as inhibitors of bet proteins
10/15/15Methods for treating disorders associated with human signal peptide-containing molecules
10/08/15N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines as pi3k inhibitors
09/10/15Topical formulation for a jak inhibitor
09/03/15Jak1 inhibitors for the treatment of myelodysplastic syndromes
08/27/15Heteroaryl substituted pyrrolo[2,3-b] pyridines and pyrrolo[2,3-b] pyrimidines as janus kinase inhibitors
08/13/15Cyclopropylamines as lsd1 inhibitors
08/13/15Cyclopropylamines as lsd1 inhibitors
08/13/15Cyclopropylamines as lsd1 inhibitors
08/13/15Cyclopropylamines as lsd1 inhibitors
08/13/15Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors
08/06/15Processes for preparing jak inhibitors and related intermediate compounds
07/30/15Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1
07/09/151,2,5-oxadiazoles as inhibitors of indoleamine 2,3- dioxygenase
07/02/15Processes and intermediates for making a jak inhibitor
Patent Packs
06/25/15Tricyclic heterocycles as bet protein inhibitors
06/18/15Metabolites of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
05/28/15Bicyclic heterocycles as bet protein inhibitors
05/28/15Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)- imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same
05/28/15Bicyclic heterocycles as bet protein inhibitors
05/28/15Bicyclic heterocycles as bet protein inhibitors
05/14/15Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor
03/26/15Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidines derivatives as jak inhibitors
03/26/15Cyclobutane and methylcyclobutane derivatives as janus kinase inhibitors
03/05/15Survival benefit in patients with solid tumors with elevated c-reactive protein levels
03/05/15Sustained release dosage forms for a jak1 inhibitor
02/26/15Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors
01/22/15Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases
01/15/15Antibodies to human transmembrane proteins
01/08/15Tricyclic heterocycles as bet protein inhibitors
Patent Packs
01/01/15Secreted proteins
12/25/14Modulators of indoleamine 2,3-dioxygenase and methods of using the same
12/25/14Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
12/18/14Purinone derivatives as hm74a agonists
11/20/14Bipyrazole derivatives as jak inhibitors
10/23/141,2,5-oxadiazoles as inhibitors of indoleamine 2,3- dioxygenase
09/18/14Tricyclic heterocycles as bet protein inhibitors
09/18/14Piperidin-4-yl azetidine derivatives as jak1 inhibitors
09/18/14Substituted heteroaryl fused derivatives as pi3k inhibitors
09/11/14Processes and intermediates for making a jak inhibitor
09/04/14Use of pyrazolopyrimidine derivatives for the treatment of pi3k-delta related disorders
08/28/14Polynucleotides encoding signal peptide-containing molecules
08/28/14Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
08/28/14Heteroaryl substituted pyrrolo[2,3-b] pyridines and pyrrolo[2,3-b] pyrimidines as janus kinase inhibitors
08/14/14Methods of treating and diagnosing pancreatitis
08/14/14Antibodies to human signal peptide-containing proteins
08/14/14Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitors
08/07/14N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
07/17/14Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitors
07/17/14Thiazolecarboxamides and pyridinecarboxamide compounds useful as pim kinase inhibitors
07/03/14Aza spiro alkane derivatives as inhibitors of metalloproteases
06/19/14Fused pyrazoles as fgfr inhibitors
06/19/14Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors
06/05/14Methods for diagnosing cancer
06/05/143-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors
06/05/14Piperazinylpiperidine derivatives as chemokine receptor antagonists
05/15/14Sustained-release dosage forms of ruxolitinib
05/01/14Tricyclic fused thiophene derivatives as jak inhibitors
05/01/14Pyrimidinones as pi3k inhibitors
03/06/14Substituted diamino-pyrimidine and diamino-pyridine derivatives as pi3k inhibitors
Social Network Patent Pack
02/27/14Secreted proteins
02/27/14Pyrimidine-4,6-diamine derivatives as pi3k inhibitors
02/13/14Pyrazine derivatives as fgfr inhibitors
01/30/14Azepine inhibitors of janus kinases
01/23/141,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
01/16/14Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
01/02/14Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
01/02/14Heteroaryl substituted pyrrolo[2,3-b] pyridines and pyrrolo[2,3-b] pyrimidines as janus kinase inhibitors
12/26/13Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
12/26/13Imidazo[1,2-b][1,2,4]triazines as c-met inhibitors
Patent Packs
12/05/13Imidazotriazines and imidazopyrimidines as kinase inhibitors
09/26/13Processes for preparing jak inhibitors and related intermediate compounds
09/26/13Processes for preparing jak inhibitors and related intermediate compounds
09/26/13Processes for preparing jak inhibitors and related intermediate compounds
09/19/13Signal peptide-containing proteins
09/19/13Polynucleotides encoding signal peptide-containing molecules
09/19/13Substituted heterocyclic compounds
08/29/13Methods of using chemokine panec-1 antibodies
08/29/13Azetidine and cyclobutane derivatives as jak inhibitors
07/25/13Polynucleotides encoding human signal peptide-containing proteins
07/11/13N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
05/30/13Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
05/16/13Modulators of indoleamine 2,3-dioxygenase and methods of using the same
05/09/133-aminopyrrolidine derivatives as modulators of chemokine receptors
04/18/13Isoindolinone and pyrrolopyridinone derivatives as akt inhibitors
03/07/13Human beta-adrenergic receptor kinase polypeptide and methods
03/07/13Heterocyclylamines as pi3k inhibitors
03/07/13Processes and intermediates for making a jak inhibitor
02/21/13Cyclohexyl azetidine derivatives as jak inhibitors
01/17/13Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors
01/17/13Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1
12/27/12Azepine inhibitors of janus kinases
11/29/12Janus kinase inhibitors for treatment of dry eye and other eye related diseases
11/22/12Piperazinylpiperidine derivatives as chemokine receptor antagonists
10/25/12Human transmembrane proteins
05/17/12Lactam compounds and their use as pharmaceuticals
02/16/12N-substituted piperidines and their use as pharmaceuticals
02/09/12Purinone derivatives as hm74a agonists
01/19/12Human beta-adrenergic receptor kinase polypeptide and methods
01/19/12Amido compounds and their use as pharmaceuticals
Patent Packs
10/13/11Macrocyclic compounds and their use as kinase inhibitors
09/01/11Imidazo[1,2-b][1,2,4]triazines as c-met inhibitors
08/25/11Cyclobutane and methylcyclobutane derivatives as janus kinase inhibitors
06/09/11Imidazotriazines and imidazopyrimidines as kinase inhibitors
04/14/11Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7h-pyrrolo[2,3-d] pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
04/07/11Metabolites of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
03/03/11Polynucleotides encoding signal peptide-containing molecules
11/04/10Methods of treatment with antibodies to a chemokine expressed in inflamed adenoid
10/07/10Amido compounds and their use as pharmaceuticals
09/23/10Substituted heterocyclic compounds
08/12/103-aminocyclopentanecarboxamides as modulators of chemokine receptors
07/29/10Macrocyclic compounds and their use as kinase inhibitors
07/08/10Substituted heterocyclic compounds
06/03/102-methylprop anamides and their use as pharmaceuticals
05/13/103-aminocyclopentanecarboxamides as modulators of chemokine receptors
04/22/10Secreted proteins
12/24/094-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as janus kinase inhibitors
11/26/09Lactam compounds and their use as pharmaceuticals
11/19/09Purinone derivatives as hm74a agonists
11/19/09Macrocyclic compounds and their use as kinase inhibitors
Social Network Patent Pack
11/05/09Human phospholipases
09/17/09Azetidine and cyclobutane derivatives as jak inhibitors
08/27/09Tetracyclic inhibitors of janus kinases
08/06/09Piperazinylpiperidine derivatives as chemokine receptor antagonists
07/16/09Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
05/14/09Aza spiro alkane derivatives as inhibitors of metalloproteases
04/02/09Purinone derivatives as hm74a agonists
03/19/09Purinone derivatives as hm74a agonists
10/18/12Compositions, methods and kits relating to her-2 cleavage
03/08/121,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
01/19/12Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitors
12/22/11Modulators of indoleamine 2,3-dioxygenase and methods of using the same
09/15/11Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
09/15/11Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
07/14/11N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
07/07/11N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
04/14/11Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitors
12/03/09Inhibitors of 11-beta hydroxyl steroid dehydrogenase type i and methods of using the same
08/06/09Azepine inhibitors of janus kinases







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Incyte Corporation in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Incyte Corporation with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';